ASHLIE FLYNN: Open Payments
NPI 1972257483 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 6 companies in 2025. Trend: 2023 $151 · 2024 $432 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| REVANCE THERAPEUTICS, INC. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: VRAYLAR, BREZTRI, DAXXIFY, Veozah, MOUNJARO, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
